Publication | Open Access

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib

Surgical OncologyLeast ImatinibGastrointestinal OncologyMedicineGastroenterologyGastrointestinal Stromal TumorsPathologyCancer TreatmentOncologyRadiation Oncology